BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 21058497)

  • 1. For debate: that Australia should consider changing to the bivalent vaccine.
    Stern PL
    Sex Health; 2010 Sep; 7(3):238-41. PubMed ID: 21058497
    [No Abstract]   [Full Text] [Related]  

  • 2. Commentary on opinion pieces re Australian human papillomavirus vaccine policy.
    McIntyre P
    Sex Health; 2010 Sep; 7(3):242-3. PubMed ID: 21058498
    [No Abstract]   [Full Text] [Related]  

  • 3. Cervical cancer vaccine development.
    Frazer IH
    Sex Health; 2010 Sep; 7(3):230-4. PubMed ID: 20719210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. For debate: that Australia should continue using the quadrivalent vaccine.
    Wain G
    Sex Health; 2010 Sep; 7(3):235-7. PubMed ID: 21058496
    [No Abstract]   [Full Text] [Related]  

  • 5. [The first vaccine for prevention of cervix cancer and other human papillomavirus related diseases gets a positive evaluation by the European Drug Authority].
    Kinderkrankenschwester; 2006 Sep; 25(9):389-90. PubMed ID: 17017592
    [No Abstract]   [Full Text] [Related]  

  • 6. Genital human papillomavirus infections.
    Kaliterna V; Barisic Z
    Front Biosci (Landmark Ed); 2018 Mar; 23(9):1587-1611. PubMed ID: 29293452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fewer shots proposed to increase uptake of HPV vaccine.
    Dorans K
    Nat Med; 2010 Aug; 16(8):832-3. PubMed ID: 20689528
    [No Abstract]   [Full Text] [Related]  

  • 8. [Diseases caused by human papilloma viruses].
    Zollner U; Schwarz TF
    Dtsch Med Wochenschr; 2011 May; 136(20):1067-72. PubMed ID: 21560109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Current immunization committee includes vaccination against human papillomaviruses in the immunization schedule].
    Kinderkrankenschwester; 2007 May; 26(5):205. PubMed ID: 17550093
    [No Abstract]   [Full Text] [Related]  

  • 10. [A vaccine to control cervix carcinoma will soon be available].
    Vetter C
    MMW Fortschr Med; 2006 Apr; 148(16):14. PubMed ID: 16688942
    [No Abstract]   [Full Text] [Related]  

  • 11. Monitoring the control of human papillomavirus (HPV) infection and related diseases in Australia: towards a national HPV surveillance strategy.
    Brotherton JM; Kaldor JM; Garland SM
    Sex Health; 2010 Sep; 7(3):310-9. PubMed ID: 20719220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advancements in the control of genital human papillomavirus infections and related diseases: highlighting Australia's role.
    Garland SM; Brotherton JM; Fairley CK; Gertig DM; Saville M
    Sex Health; 2010 Sep; 7(3):227-9. PubMed ID: 21058495
    [No Abstract]   [Full Text] [Related]  

  • 13. HPV vaccination--more answers, more questions.
    Sawaya GF; Smith-McCune K
    N Engl J Med; 2007 May; 356(19):1991-3. PubMed ID: 17494933
    [No Abstract]   [Full Text] [Related]  

  • 14. Cytology and cervical cancer surveillance in an era of human papillomavirus vaccination.
    Budd AC; Sturrock CJ
    Sex Health; 2010 Sep; 7(3):328-34. PubMed ID: 20719223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Papillomavirus vaccine types 16 and 18: new drug. Cervical cancer: just another vaccine.
    Prescrire Int; 2008 Jun; 17(95):103-4. PubMed ID: 18623911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Knowledge of human papillomavirus (HPV) and the HPV vaccine in a national sample of Australian men and women.
    Pitts MK; Heywood W; Ryall R; Smith AM; Shelley JM; Richters J; Simpson JM
    Sex Health; 2010 Sep; 7(3):299-303. PubMed ID: 20719218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quadrivalent human vaccine - a call to action and for additional research.
    Krogstad P; Cherry JD
    Pediatr Res; 2007 Nov; 62(5):527. PubMed ID: 18049369
    [No Abstract]   [Full Text] [Related]  

  • 18. Population-level impact of the bivalent, quadrivalent, and nonavalent human papillomavirus vaccines: a model-based analysis.
    Van de Velde N; Boily MC; Drolet M; Franco EL; Mayrand MH; Kliewer EV; Coutlée F; Laprise JF; Malagón T; Brisson M
    J Natl Cancer Inst; 2012 Nov; 104(22):1712-23. PubMed ID: 23104323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Vaccination against human papillomaviridae. Expert correspondence no. 18 of 29 December 2006].
    Kommission Qualitätssicherung der Schweizerischen Gesellschaft für Gynäkologie und Geburtshilfe
    Gynakol Geburtshilfliche Rundsch; 2007; 47(2):101-2. PubMed ID: 17440273
    [No Abstract]   [Full Text] [Related]  

  • 20. NIH lab helps get vaccine from bench to bedside.
    Traynor K
    Am J Health Syst Pharm; 2007 Mar; 64(5):452. PubMed ID: 17322152
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.